KOSDAQ · Healthcare · ₩63B
₩2,675+2.10%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 0.4% · as of 26.10.27
Among 98 제약 peers
Quarterly Revenue Growth
“매출보다 이익이 더 빠르게 자라 회사 체질이 한층 좋아졌어요.”
In the company's words · 2026 2분기 filing